Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Generex Biotechnology (GNBT)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for GNBT as compared to
Top Competitors
Drug Delivery
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
1.12M
VERY LOW
EBITDA
►
-8.95M
AVG
Net Income
►
-45.8M
AVG
Revenue Growth
►
796%
VERY HIGH
Operating Margin
►
-2325.1%
VERY LOW
Net Margin
►
-4094%
VERY LOW
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.745
AVG
Current Ratio
►
1.87
AVG
Quick Ratio
►
1.72
AVG
Interest Coverage Ratio
►
-1.28
AVG
Book Value Per Share
►
0.0576
Cash Per Share
►
0.0575
Loading...
STOCK SUMMARY
Open
0.49
Day Range
0.46
-
0.52
52 Week Range
0.08
-
1.14
Volume
844K
Avg Volume (3 mo)
5.34M
Shares Outstanding
244M
Market Cap
122M
VALUATION
Price to Earnings (P/E)
►
-3.75
Price to Book (P/B)
►
12.1
HIGH
Price to Sales (P/S)
►
153
VERY HIGH
Return on Assets (ROA)
►
-81.6%
LOW
Return on Equity (ROE)
►
-248.5%
AVG
EV/EBITDA
►
-21.0
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
-2%
Net Insider Buying 6mo
-2%
Net Insider Buying 1yr
-1.3%
Held by insiders
0.6%
Held by institutions
0.7%
No Sales Breakout Data.